Your browser doesn't support javascript.
loading
A severe case of neuro-Sjögren's syndrome induced by pembrolizumab.
Ghosn, Jaqueline; Vicino, Alex; Michielin, Olivier; Coukos, George; Kuntzer, Thierry; Obeid, Michel.
Affiliation
  • Ghosn J; Department of Medicine, Division of Immunology and Allergy, Lausanne University Hospital CHUV, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
  • Vicino A; Department of Neurology, Lausanne University Hospital CHUV, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
  • Michielin O; Department of Medical Oncology, Lausanne University Hospital CHUV, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
  • Coukos G; Department of Medical Oncology, Lausanne University Hospital CHUV, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
  • Kuntzer T; Ludwig Institute for Cancer Research, Chemin des Boveresses 155, CH-1066, Epalinges, Switzerland.
  • Obeid M; Department of Neurology, Lausanne University Hospital CHUV, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
J Immunother Cancer ; 6(1): 110, 2018 10 22.
Article in En | MEDLINE | ID: mdl-30348223

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sjogren's Syndrome / Neurotoxicity Syndromes / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological Type of study: Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: J Immunother Cancer Year: 2018 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sjogren's Syndrome / Neurotoxicity Syndromes / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological Type of study: Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: J Immunother Cancer Year: 2018 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom